Previous close | 125.50 |
Open | 125.50 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 800 |
Day's range | 124.04 - 126.56 |
52-week range | 100.39 - 135.05 |
Volume | |
Avg. volume | 1,390,290 |
Market cap | 26.416B |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | 81.74 |
EPS (TTM) | 1.54 |
Earnings date | 03 Feb 2023 |
Forward dividend & yield | 0.96 (0.76%) |
Ex-dividend date | 23 Dec 2022 |
1y target est | 128.13 |
Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zimmer Biomet (ZBH) is expected to have witnessed continued recovery in its legacy business in the fourth quarter, despite the choppy market situation.
In one of the biggest deals announced this past week, Phillips 66 agreed to pay $3.8 billion and take an 87% stake in DCP Midstream. DCP Midstream (NYSE:DCP) gained more than 6% after Phillips 66 (NYSE:PSX) agreed to pay $3.8 billion in cash for all of the publicly held common units representing limited partner interests in DCP, increasing its stake in DCP to 86.8%. Phillips 66 shares gained some 2%.